Virtual reality hypnotherapy for healthcare students

ISRCTN ISRCTN17356993
DOI https://doi.org/10.1186/ISRCTN17356993
IRAS number 22022.0122
Submission date
31/12/2023
Registration date
03/01/2024
Last edited
03/01/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Poor student mental health is a priority for universities and there is some evidence that both hypnotherapy and virtual reality (VR) can be helpful in reducing perceived stress in the general population. This is a feasibility trial of an intervention combining hypnotherapy and VR which was trialled in a group of healthcare students.

Who can participate?
Students aged over 18 years registered at St George’s University of London

What does the study involve?
The students will be asked to try the VR hypnotherapy experience once a day over 3 days, and it lasts about 7 minutes.
The students will be asked to complete some questionnaires regarding their wellbeing and anxiety levels before and after the 3-day trial, and scales before and after each session measuring how relaxed/happy/sad they feel on a scale of 1 to 10. Pulse and blood pressure will be measured before and after each experience and at the end of the 3 days the students will be asked how they found it overall, what was good and what was bad about it.

What are the possible benefits and risks of participating?
The main risk is of feeling nauseous (cybersickness). Students will have an opportunity to try a novel experience.

Where is the study run from?
St George's, University of London (UK)

When is the study starting and how long is it expected to run for?
February 2021 to July 2022

Who is funding the study?
St George's, University of London (UK)

Who is the main contact?
Dr Aileen O’Brien, aobrien@sgul.ac.uk

Contact information

Dr Aileen O'Brien
Public, Scientific, Principal Investigator

SGUL
London
SW17
United Kingdom

ORCiD logoORCID ID 0000-0002-2824-7190
Phone +44 (0)7961174521
Email aobrien@sgul.ac.uk

Study information

Study designSingle-arm non-randomized feasibility pilot trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)University/medical school/dental school
Study typeOther
Scientific titleVirtual reality hypnotherapy for healthcare students: a feasibility trial
Study hypothesisA virtual reality hypnotherapy experience will be tolerated and acceptable to healthcare students
Ethics approval(s)

Approved 06/06/2022, St George’s Research Ethics Committee (SGREC) (SGUL, Cranmer Terrace, Tooting, London, SW17 7DJ, United Kingdom; +44 (0)208 266 6073; sgulrec@sgul.ac.uk), ref: 22022.0122

ConditionPerceived stress
InterventionThis was a pilot so there was only one arm and no randomisation. Students who volunteered for the trial and met the eligibility criteria were allocated a project id and their sex, age group and ethnicity were recorded. Participants were asked to attend a quiet annex of the Student Union for a maximum of 1 hour each day (timed for the end of the teaching day) on three consecutive days. Students tried the virtual reality hypnotherapy experience over 3 days each lasting 7 minutes, involving the voice of a clinical hypnotherapist guiding the user through a series of virtual spaces.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Virtual reality hypnotherapy in oculus headset
Primary outcome measure1. Wellbeing measured using the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) at the start of the first session and the end of the third session
2. Perceived stress measured using the Perceived Stress Scale (PSS) at the start of the first session and the end of the third session
3. Depression measured using the Patient Health Questionnaire-2 (PHQ2) at the start of the first session and the end of the third session
4. Anxiety measured using the Generalized Anxiety Disorder (GAD-7) questionnaire at the start of the first session and the end of the third session
5. Stress, happiness, sadness, calm, and anxiety measured using visual analogue scales before and after each VR session
6. Students’ experience of the VR assessed using qualitative analysis of an open-ended question at the end of the 3 days
Secondary outcome measuresPulse and blood pressure readings assessed as proxy indicators of stress by junior doctors manually (pulse) and with an electronic blood pressure reader before and after each VR session
Overall study start date01/02/2021
Overall study end date26/07/2022

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants20
Total final enrolment14
Participant inclusion criteria1. Aged over 18 years
2. Student at St George's University of London
Participant exclusion criteria1. Epilepsy
2. Pacemaker
Recruitment start date07/06/2022
Recruitment end date15/06/2022

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St George's University of London
Cranmer Terrace
London
SW17 7DJ
United Kingdom

Sponsor information

St George's, University of London
University/education

Cranmer Terrace
Tooting
London
Sw177DJ
England
United Kingdom

Phone +44 (0)2087255000
Email rallen@sgul.ac.uk
Website http://www.sgul.ac.uk/

Funders

Funder type

University/education

St. George's, University of London
Private sector organisation / Universities (academic only)
Alternative name(s)
St. George's
Location
United Kingdom

Results and Publications

Intention to publish date01/02/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planTo publish in a peer reviewed journal.
IPD sharing planThe datasets generated will be available on request from Dr Aileen O'Brien (aobrien@sgul.ac.uk).

Editorial Notes

02/01/2024: Study's existence confirmed by the St George’s Research Ethics Committee (SGREC).